Skip to main content

Table 2 CEA in urine and serum, histopathological type, grade of malignancy and pathological stage of nonbilharzial carcinoma of the urinary bladder.

From: Urine carcinoembryonic antigen levels are more useful than serum levels for early detection of Bilharzial and non-Bilharzial urinary bladder carcinoma: Observations of 43 Egyptian cases

Case No

Urine CEA (ng/ml)

Serum CEA (ng/ml)

Histological Type

Grade

Stage

1

22

8

Transitional

III

P3

2

10

10

Transitional

III

P1

3

14

--

Transitional

III

P2

4

30

--

Transitional

III

P3

5

8

4

Anaplastic

IV

P2

6

26

3.5

Transitional

III

P2

7

160

2.5

Transitional

III

P3

8

17

3

Transitional

III

P1

9

13

3

Transitional

III

P2

10

3

5

Transitional

III

P1

11

165

0.5

Transitional

III

P2

12

135

0.5

Anaplastic

IV

P3

13

15

0.5

Transitional

II

P2

14

4

0.5

Transitional

II

P2

15

120

1

Transitional

III

P3

16

75

3

Transitional

II

P1

17

3

1

Transitional

II

P1

18

5

0

Squamous

III

P3

19

5

3

Transitional

III

P2

20

1

0

Transitional

III

P2

21

90

3

Squamous

II

P1

  1. Mean for urine CEA in non-bilharzial carcinoma = 43.86 ng/ml. (Standard deviation = 55.70 ng/ml)
  2. Mean for serum CEA in non-bilharzial carcinoma = 2.74 ng/ml. (Standard deviation = 2.68 ng/ml)
  3. Mean urine CEA in squamous cell carcinoma = 58.26 ng/ml. (Standard deviation = 42.12 ng/ml)
  4. Mean urine CEA in transitional cell carcinoma = 50.14 ng/ml. (Standard deviation = 58.31 ng/ml)
  5. Mean serum CEA in squamous cell carcinoma = 5.60 ng/ml. (Standard deviation = 5.41 ng/ml)
  6. Mean serum CEA in transitional cell carcinoma = 2.37 ng/ml. (Standard deviation = 2.79 ng/ml